3
|
Tsuboya A, Kubota Y, Ishida H, Ohkuma R, Ishiguro T, Hirasawa Y, Ariizumi H, Tsunoda T, Sasaki Y, Matsumoto N, Kondo Y, Tomoda Y, Kusuhara H, Fujita KI. Minimal contribution of the hepatic uptake transporter OATP1B1 to the inter-individual variability in SN-38 pharmacokinetics in cancer patients without severe renal failure. Cancer Chemother Pharmacol 2021; 88:543-553. [PMID: 34117512 DOI: 10.1007/s00280-021-04314-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2021] [Accepted: 06/05/2021] [Indexed: 01/08/2023]
Abstract
PURPOSE SN-38, a pharmacologically active metabolite of irinotecan, is taken up into hepatocytes by organic anion transporting polypeptide (OATP) 1B1. The effects of functional OATP1B1 521T>C on the pharmacokinetics of SN-38 remain controversial. Here, we prospectively examined the effects of OATP1B1 function on the area under the plasma total or unbound concentration-time curve (tAUC or uAUC) of SN-38 by assessing OATP1B1 521T>C and the plasma levels of endogenous OATP1B1 substrates, coproporphyrin (CP)-I and III, in cancer patients treated with irinotecan. METHODS We enrolled cancer patients who were treated with an irinotecan-containing regimen and did not have severe renal failure. The total and unbound concentrations of SN-38 in the plasma were measured by high-performance liquid chromatography. AUC values were calculated and normalized to the actual irinotecan dose (AUC/dose). The OATP1B1 521T>C was analyzed by direct sequencing. Concentrations of the endogenous substrates in plasma before irinotecan treatment (baseline) were determined by liquid chromatography with tandem mass spectrometry. RESULTS Twenty-two patients with a median estimated glomerular filtration rate of 74.8 mL/min (range 32.6-99.6) were examined. Both tAUC/dose and uAUC/dose were associated with the grade of neutropenia; however, they were not associated with OATP1B1 521T>C or baseline CP-I and III levels. It is worth noting that these baseline concentrations were significantly higher in patients with OATP1B1 521C, supporting functional changes in OATP1B1. CONCLUSION The contribution of OATP1B1 activity to inter-patient variability in the systemic exposure to SN-38 is likely minimal in patients without severe renal failure.
Collapse
Affiliation(s)
- Ayako Tsuboya
- Division of Pharmaceutical Regulatory Pharmacy, Department of Healthcare and Regulatory Sciences, Showa University School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.,Department of Pharmacy, Kawasaki Municipal Tama Hospital, 1‑30‑37, Shukugawara, Tama‑ku, Kawasaki, Kanagawa, 214‑8525, Japan
| | - Yutaro Kubota
- Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan
| | - Hiroo Ishida
- Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan
| | - Ryotaro Ohkuma
- Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan
| | - Tomoyuki Ishiguro
- Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan
| | - Yuya Hirasawa
- Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan
| | - Hirotsugu Ariizumi
- Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan
| | - Takuya Tsunoda
- Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan
| | - Yasutsuna Sasaki
- Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan
| | - Natsumi Matsumoto
- Division of Cancer Genome and Pharmacotherapy, Department of Clinical Pharmacy, Showa University School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan
| | - Yusuke Kondo
- Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongou, Bunkyo-ku, Tokyo, 113-0033, Japan
| | - Yukana Tomoda
- Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongou, Bunkyo-ku, Tokyo, 113-0033, Japan
| | - Hiroyuki Kusuhara
- Laboratory of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongou, Bunkyo-ku, Tokyo, 113-0033, Japan
| | - Ken-Ichi Fujita
- Division of Cancer Genome and Pharmacotherapy, Department of Clinical Pharmacy, Showa University School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
| |
Collapse
|
5
|
Ie K, Hirose M, Sakai T, Motohashi I, Aihara M, Otsuki T, Tsuboya A, Matsumoto H, Hashi H, Inoue E, Takahashi M, Komiya E, Itoh Y, Tsuchida T, Kurosu E, Albert SM, Okuse C, Matsuda T. Protocol of a randomised controlled trial on the efficacy of medication optimisation in elderly inpatients: medication optimisation protocol efficacy for geriatric inpatients (MPEG) trial. BMJ Open 2020; 10:e041125. [PMID: 33046478 PMCID: PMC7552871 DOI: 10.1136/bmjopen-2020-041125] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
INTRODUCTION Whether medication optimisation improves clinical outcomes in elderly individuals remains unclear. The current study aims to evaluate the effect of multidisciplinary team-based medication optimisation on survival, rehospitalisation and unscheduled hospital visits in elderly patients. METHODS AND ANALYSIS We report the protocol of a single-centre, open-label, randomised controlled trial. The enrolled subjects will be medical inpatients, aged 65 years or older, admitted to a community hospital and receiving five or more regular medications. The participants will be randomly assigned to receive either an intervention for medication optimisation or the usual care. The intervention will consist of a multidisciplinary team-based medication review, followed by a medication optimisation proposal based on the Screening Tool of Older Persons' potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment criteria and an implicit medication optimisation protocol. Medication optimisation summaries will be sent to primary care physicians and community pharmacists on discharge. The primary outcome will be a composite of death, unscheduled hospital visits and rehospitalisation until 48 weeks after randomisation. Secondary outcomes will include each of the primary endpoints, the number of prescribed medications, quality of life score, level of long-term care required, drug-related adverse events, death during hospitalisation and falls. Participants will be followed up for 48 weeks with bimonthly telephone interviews to assess the primary and secondary outcomes. A log-rank test stratified by randomisation factors will be used to compare the incidence of the composite endpoint. The study was initiated in 2019 and a minimum of 500 patients will be enrolled. ETHICS AND DISSEMINATION The study protocol has been approved by the Institutional Ethical Committee of St. Marianna University School of Medicine (No. 4129). The results of the current study will be submitted to a peer-reviewed journal. TRIAL REGISTRATION NUMBER UMIN000035265.
Collapse
Affiliation(s)
- Kenya Ie
- Division of General Internal Medicine, Department of Internal Medicine, Kawasaki Municipal Tama Hospital, Kawasaki-shi, Kanagawa, Japan
- Division of General Internal Medicine, Department of Internal Medicine, St Marianna University School of Medicine, Kawasaki-shi, Kanagawa, Japan
| | - Masanori Hirose
- Division of General Internal Medicine, Department of Internal Medicine, St Marianna University School of Medicine, Kawasaki-shi, Kanagawa, Japan
| | - Tsubasa Sakai
- Division of General Internal Medicine, Department of Internal Medicine, Kawasaki Municipal Tama Hospital, Kawasaki-shi, Kanagawa, Japan
- Division of General Internal Medicine, Department of Internal Medicine, St Marianna University School of Medicine, Kawasaki-shi, Kanagawa, Japan
| | - Iori Motohashi
- Division of General Internal Medicine, Department of Internal Medicine, Kawasaki Municipal Tama Hospital, Kawasaki-shi, Kanagawa, Japan
- Division of General Internal Medicine, Department of Internal Medicine, St Marianna University School of Medicine, Kawasaki-shi, Kanagawa, Japan
| | - Mari Aihara
- Division of General Internal Medicine, Department of Internal Medicine, Kawasaki Municipal Tama Hospital, Kawasaki-shi, Kanagawa, Japan
- Division of General Internal Medicine, Department of Internal Medicine, St Marianna University School of Medicine, Kawasaki-shi, Kanagawa, Japan
| | - Takuya Otsuki
- Division of General Internal Medicine, Department of Internal Medicine, Kawasaki Municipal Tama Hospital, Kawasaki-shi, Kanagawa, Japan
- Division of General Internal Medicine, Department of Internal Medicine, St Marianna University School of Medicine, Kawasaki-shi, Kanagawa, Japan
| | - Ayako Tsuboya
- Department of Pharmacy, Kawasaki Municipal Tama Hospital, Kawasaki-shi, Kanagawa, Japan
| | - Hiroshi Matsumoto
- Department of Pharmacy, Kawasaki Municipal Tama Hospital, Kawasaki-shi, Kanagawa, Japan
| | - Hikari Hashi
- Department of Pharmacy, Kawasaki Municipal Tama Hospital, Kawasaki-shi, Kanagawa, Japan
| | - Eisuke Inoue
- Showa University Research Administration Center, Showa University, Shinagawa-ku, Tokyo, Japan
| | - Masaki Takahashi
- Division of Medical Informatics, St. Marianna University School of Medicine, Kawasaki-shi, Kanagawa, Japan
| | - Eiko Komiya
- Department of Pharmacy, Kawasaki Municipal Tama Hospital, Kawasaki-shi, Kanagawa, Japan
| | - Yuka Itoh
- Department of Pharmacy, Kawasaki Municipal Tama Hospital, Kawasaki-shi, Kanagawa, Japan
| | - Tomoya Tsuchida
- Division of General Internal Medicine, Department of Internal Medicine, St Marianna University School of Medicine, Kawasaki-shi, Kanagawa, Japan
| | - Eri Kurosu
- Division of General Internal Medicine, Department of Internal Medicine, Kawasaki Municipal Tama Hospital, Kawasaki-shi, Kanagawa, Japan
- Division of General Internal Medicine, Department of Internal Medicine, St Marianna University School of Medicine, Kawasaki-shi, Kanagawa, Japan
| | - Steven M Albert
- Department of Behavioral and Community Health Sciences, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USA
| | - Chiaki Okuse
- Division of General Internal Medicine, Department of Internal Medicine, Kawasaki Municipal Tama Hospital, Kawasaki-shi, Kanagawa, Japan
- Division of General Internal Medicine, Department of Internal Medicine, St Marianna University School of Medicine, Kawasaki-shi, Kanagawa, Japan
| | - Takahide Matsuda
- Division of General Internal Medicine, Department of Internal Medicine, St Marianna University School of Medicine, Kawasaki-shi, Kanagawa, Japan
| |
Collapse
|
7
|
Ito Y, Tsuda T, Minatogawa H, Kano S, Sakamaki K, Ando M, Tsugawa K, Kojima Y, Furuya N, Matsuzaki K, Fukuda M, Sugae S, Ohta I, Arioka H, Tokuda Y, Narui K, Tsuboya A, Suda T, Morita S, Boku N, Yamanaka T, Nakajima TE. Placebo-Controlled, Double-Blinded Phase III Study Comparing Dexamethasone on Day 1 With Dexamethasone on Days 1 to 3 With Combined Neurokinin-1 Receptor Antagonist and Palonosetron in High-Emetogenic Chemotherapy. J Clin Oncol 2018; 36:1000-1006. [PMID: 29443652 DOI: 10.1200/jco.2017.74.4375] [Citation(s) in RCA: 40] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Purpose We evaluated the noninferiority of dexamethasone (DEX) on day 1, with sparing on days 2 and 3, combined with neurokinin-1 receptor antagonist (NK1-RA) and palonosetron (Palo) compared with the 3-day use of DEX in highly-emetogenic chemotherapy (HEC). Patients and Methods Patients who were scheduled to receive HEC (cisplatin ≥ 50 mg/m2 or anthracycline plus cyclophosphamide) were randomly assigned to receive either DEX on days 1 to 3 (Arm D3) or DEX on day 1 and placebo on days 2 and 3 (Arm D1) combined with NK1-RA and Palo. The primary end point was complete response (CR), defined as no emesis and no rescue medications during the overall (0 to 120 h) phase. The noninferiority margin was set at -15.0% (Arm D1 - Arm D3). Results A total of 396 patients-196 and 200 patients in Arms D3 and D1, respectively-were evaluated. CR rates during the overall period were 46.9% for Arm D3 and 44.0% for Arm D1 (95% CI, -12.6% to 6.8%; P = .007). CR rates during the acute (0 to 24 h) phase were 63.3% and 64.5% for Arms D3 and D1, respectively (95% CI, -8.1% to 10.6%; P < .001), and they were 56.6% and 51.5%, respectively, during the delayed (24 to 120 h) phase (95% CI, -14.8% to 4.6%; P = .023). Hot flushes and tremors were observed more frequently as DEX-related adverse events on days 4 and 5 in Arm D3, whereas anorexia, depression, and fatigue were observed more frequently on days 2 and 3 in Arm D1. As an indication of quality of life, global health status was similar in both arms. Conclusion Antiemetic DEX administration on days 2 and 3 can be spared when combined with NK1-RA and Palo in HEC.
Collapse
Affiliation(s)
- Yuka Ito
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Takashi Tsuda
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Hiroko Minatogawa
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Sayaka Kano
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Kentaro Sakamaki
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Masahiko Ando
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Koichiro Tsugawa
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Yasuyuki Kojima
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Naoki Furuya
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Kunihiro Matsuzaki
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Mamoru Fukuda
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Sadatoshi Sugae
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Ichiro Ohta
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Hitoshi Arioka
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Yutaka Tokuda
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Kazutaka Narui
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Ayako Tsuboya
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Takashi Suda
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Satoshi Morita
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Narikazu Boku
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Takeharu Yamanaka
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| | - Takako Eguchi Nakajima
- Yuka Ito, Hiroko Minatogawa, and Sayaka Kano, St Marianna University School of Medicine Hospital; Takashi Tsuda, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, and Takako Eguchi Nakajima, St Marianna University School of Medicine; Ayako Tsuboya, Kawasaki Municipal Tama Hospital, Kawasaki; Kentaro Sakamaki and Takeharu Yamanaka, Yokohama City University School of Medicine; Sadatoshi Sugae and Ichiro Ohta, Yokohama City University Hospital; Hitoshi Arioka, Yokohama Rosai Hospital; Kazutaka Narui, Yokohama City University Medical Center, Yokohama; Masahiko Ando, Nagoya University Hospital, Nagoya; Yutaka Tokuda, Tokai University School of Medicine, Kanagawa; Takashi Suda, Takahata Public Hospital, Takahata-Chou; Satoshi Morita, Graduate School of Medicine, Kyoto University, Kyoto; and Narikazu Boku, National Cancer Center Hospital, Tokyo, Japan
| |
Collapse
|